| 0 |
Antimetabolite Immunosuppressant [EPC] |
5 |
0.0002 |
| 1 |
Programmed Death Ligand-1 Blocker [EPC] |
4 |
0.0002 |
| 2 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
4 |
0.0002 |
| 3 |
Somatostatin Analog [EPC] |
1 |
0.0001 |
| 4 |
Asparagine-specific Enzyme [EPC] |
1 |
0.0001 |
| 5 |
Radioligand Therapeutic Agent [EPC] |
1 |
0.0001 |
| 6 |
Stimulant Laxative [EPC] |
1 |
0.0001 |
| 7 |
Thrombopoietin Receptor Agonist [EPC] |
1 |
0.0001 |
| 8 |
Nucleoside Metabolic Inhibitor [EPC] |
18 |
0.0001 |
| 9 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
11 |
0.0001 |
| 10 |
Platinum-based Drug [EPC] |
15 |
0.0001 |
| 11 |
Polyene Antifungal [EPC] |
2 |
0.0000 |
| 12 |
Bile Acid [EPC] |
1 |
0.0000 |
| 13 |
CTLA-4-directed Blocking Antibody [EPC] |
2 |
0.0000 |
| 14 |
Microtubule Inhibitor [EPC] |
6 |
0.0000 |
| 15 |
Penem Antibacterial [EPC] |
1 |
0.0000 |
| 16 |
Benzodiazepine [EPC] |
17 |
0.0000 |
| 17 |
Estrogen Receptor Antagonist [EPC] |
1 |
0.0000 |
| 18 |
Nucleoside Analog Antiviral [EPC] |
2 |
0.0000 |
| 19 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
3 |
0.0000 |
| 20 |
Integrin Receptor Antagonist [EPC] |
2 |
0.0000 |
| 21 |
beta3-Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 22 |
Azole Antifungal [EPC] |
3 |
0.0000 |
| 23 |
Antirheumatic Agent [EPC] |
2 |
0.0000 |
| 24 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
2 |
0.0000 |
| 25 |
Parathyroid Hormone Analog [EPC] |
2 |
0.0000 |
| 26 |
Complement Inhibitor [EPC] |
1 |
0.0000 |
| 27 |
Osmotic Laxative [EPC] |
5 |
0.0000 |
| 28 |
Alkylating Drug [EPC] |
4 |
0.0000 |
| 29 |
Cholinergic Nicotinic Agonist [EPC] |
1 |
0.0000 |
| 30 |
Serotonin-3 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 31 |
Expectorant [EPC] |
3 |
0.0000 |
| 32 |
Vitamin C [EPC] |
6 |
0.0000 |
| 33 |
alpha-Adrenergic Blocker [EPC] |
2 |
0.0000 |
| 34 |
Tetracycline-class Drug [EPC] |
1 |
0.0000 |
| 35 |
GLP-1 Receptor Agonist [EPC] |
6 |
0.0000 |
| 36 |
Janus Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 37 |
Platelet Aggregation Inhibitor [EPC] |
7 |
0.0000 |
| 38 |
Histamine-1 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 39 |
Serotonin Reuptake Inhibitor [EPC] |
1 |
0.0000 |
| 40 |
Opioid Agonist [EPC] |
3 |
0.0000 |
| 41 |
Corticosteroid [EPC] |
14 |
0.0000 |
| 42 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
1 |
0.0000 |
| 43 |
HMG-CoA Reductase Inhibitor [EPC] |
4 |
0.0000 |
| 44 |
Estrogen [EPC] |
2 |
0.0000 |
| 45 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
1 |
0.0000 |
| 46 |
Aminosalicylate [EPC] |
1 |
0.0000 |
| 47 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
13 |
0.0000 |
| 48 |
Vitamin D [EPC] |
3 |
0.0000 |
| 49 |
Interleukin-12 Antagonist [EPC] |
1 |
0.0000 |
| 50 |
Interleukin-23 Antagonist [EPC] |
1 |
0.0000 |
| 51 |
Vitamin B12 [EPC] |
3 |
0.0000 |
| 52 |
Anti-epileptic Agent [EPC] |
2 |
0.0000 |
| 53 |
Aromatase Inhibitor [EPC] |
1 |
0.0000 |
| 54 |
P2Y12 Platelet Inhibitor [EPC] |
1 |
0.0000 |
| 55 |
Fluoroquinolone Antibacterial [EPC] |
1 |
0.0000 |
| 56 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 57 |
Prostacycline Vasodilator [EPC] |
1 |
0.0000 |
| 58 |
Folate Analog Metabolic Inhibitor [EPC] |
3 |
0.0000 |
| 59 |
Calcium [EPC] |
1 |
0.0000 |
| 60 |
Atypical Antipsychotic [EPC] |
3 |
0.0000 |
| 61 |
Loop Diuretic [EPC] |
3 |
0.0000 |
| 62 |
beta-Adrenergic Blocker [EPC] |
2 |
0.0000 |
| 63 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 64 |
Angiotensin 2 Receptor Blocker [EPC] |
2 |
0.0000 |
| 65 |
Phosphodiesterase 4 Inhibitor [EPC] |
1 |
0.0000 |
| 66 |
Proton Pump Inhibitor [EPC] |
3 |
0.0000 |
| 67 |
Tumor Necrosis Factor Blocker [EPC] |
5 |
0.0000 |
| 68 |
Endothelin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 69 |
Thiazide Diuretic [EPC] |
1 |
0.0000 |
| 70 |
Mood Stabilizer [EPC] |
1 |
0.0000 |
| 71 |
Retinoid [EPC] |
1 |
0.0000 |
| 72 |
Dihydropyridine Calcium Channel Blocker [EPC] |
1 |
0.0000 |
| 73 |
Insulin Analog [EPC] |
1 |
0.0000 |
| 74 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
1 |
0.0000 |